ANGELA JESSIE: Open Payments
NPI 1720050818 · EDMONTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$331 in 18 payments from 7 companies in 2025. Trend: 2023 $316 · 2024 $402 · 2025 $331
Food & beverage: $331
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $70 |
| Vanda Pharmaceuticals Inc. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, FANAPT, REXULTI, INVEGA SUSTENNA, TRINTELLIX, Cologuard Collection Kit.
Industry payments across KY — which companies pay providers there.
